Eli Lilly and EVA Pharma have announced approval from the Egyptian Drug Authority for the human insulin glargine injection to treat type 1 and type 2 diabetic patients. EVA Pharma manufactures the ...
Egypt's Ministry of health and Population announced on Saturday that the Egyptian Drug Authority (EDA) officially received the Level 3 maturity certificate (ML3) for medicines and vaccines ...
The World Health Organization (WHO) announced Friday 20/12/2024 that the Egyptian Drug Authority (EDA) has achieved Level 3 maturity for regulatory authorities. Egypt has achieved a significant ...
The Egyptian Drug Authority approved the insulin glargine injection manufactured by EVA Pharma through a collaboration with Eli Lilly and Company. Launched in 2022, the collaboration aims to deliver a ...
Addis Ababa, Ethiopia — 22 December 2024 - The Africa Centres for Disease Control and Prevention (Africa CDC) congratulates the Egyptian Drug Authority (EDA) on its historic milestone of earning ...
Representatives from the Egyptian Drug Authority (EDA) also participated. The discussions centered on forging partnerships to ensure access to safe, high-quality medicines while fostering ...